- Home
- OXLCO vs OCEAW Comparison
OXLCO vs OCEAW Comparison
Compare OXLCO & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXLCO
- OCEAW
- Stock Information
- Founded
- OXLCO N/A
- OCEAW N/A
- Country
- OXLCO United States
- OCEAW United States
- Employees
- OXLCO N/A
- OCEAW 7
- Industry
- OXLCO Investment Managers
- OCEAW Biotechnology: Pharmaceutical Preparations
- Sector
- OXLCO Finance
- OCEAW Health Care
- Exchange
- OXLCO Nasdaq
- OCEAW Nasdaq
- Market Cap
- OXLCO N/A
- OCEAW N/A
- IPO Year
- OXLCO N/A
- OCEAW 2021
- Fundamental
- Price
- OXLCO $23.07
- OCEAW $0.03
- Analyst Decision
- OXLCO
- OCEAW
- Analyst Count
- OXLCO 0
- OCEAW 0
- Target Price
- OXLCO N/A
- OCEAW N/A
- AVG Volume (30 Days)
- OXLCO N/A
- OCEAW N/A
- Earning Date
- OXLCO N/A
- OCEAW N/A
- Dividend Yield
- OXLCO N/A
- OCEAW N/A
- EPS Growth
- OXLCO N/A
- OCEAW N/A
- EPS
- OXLCO N/A
- OCEAW N/A
- Revenue
- OXLCO N/A
- OCEAW N/A
- Revenue This Year
- OXLCO N/A
- OCEAW N/A
- Revenue Next Year
- OXLCO N/A
- OCEAW N/A
- P/E Ratio
- OXLCO N/A
- OCEAW N/A
- Revenue Growth
- OXLCO N/A
- OCEAW N/A
- 52 Week Low
- OXLCO N/A
- OCEAW N/A
- 52 Week High
- OXLCO N/A
- OCEAW N/A
- Technical
- Relative Strength Index (RSI)
- OXLCO 55.35
- OCEAW N/A
- Support Level
- OXLCO $22.91
- OCEAW N/A
- Resistance Level
- OXLCO $23.10
- OCEAW N/A
- Average True Range (ATR)
- OXLCO 0.04
- OCEAW 0.00
- MACD
- OXLCO -0.01
- OCEAW 0.00
- Stochastic Oscillator
- OXLCO 84.21
- OCEAW 0.00
About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.